SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 102 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -48.1% | 2,200 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | -25.0% | 2,200 | 0.0% | 0.00% | – |
| Q3 2021 | $72,000 | -76.2% | 2,200 | -79.0% | 0.00% | -100.0% |
| Q2 2021 | $303,000 | -37.0% | 10,500 | +10.5% | 0.00% | -50.0% |
| Q1 2021 | $481,000 | -43.0% | 9,500 | -45.4% | 0.00% | -33.3% |
| Q4 2020 | $844,000 | +155.8% | 17,400 | -7.0% | 0.00% | +200.0% |
| Q3 2020 | $330,000 | -29.9% | 18,700 | -27.8% | 0.00% | -50.0% |
| Q2 2020 | $471,000 | +63.5% | 25,900 | +8.8% | 0.00% | 0.0% |
| Q1 2020 | $288,000 | -8.0% | 23,800 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $313,000 | -26.5% | 23,800 | -50.0% | 0.00% | 0.0% |
| Q3 2019 | $426,000 | +13.0% | 47,600 | +100.0% | 0.00% | -50.0% |
| Q2 2019 | $377,000 | +1042.4% | 23,800 | +1222.2% | 0.00% | – |
| Q1 2019 | $33,000 | -19.5% | 1,800 | 0.0% | 0.00% | – |
| Q4 2018 | $41,000 | -10.9% | 1,800 | 0.0% | 0.00% | – |
| Q3 2018 | $46,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |